Avanos Medical (AVNS) Total Non-Current Liabilities (2013 - 2026)

Avanos Medical has reported Total Non-Current Liabilities for 14 years, with the latest figure at $253.9 million in Q1 2026.

• Quarterly Total Non-Current Liabilities fell 3.79% year-over-year to $253.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $253.9 million (down 3.79% YoY) and the FY2025 annual result came in at $282.0 million, down 12.23% from the prior year.
• Total Non-Current Liabilities retreated to $253.9 million in Q1 2026 per AVNS's latest filing, from $282.0 million in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $487.2 million in Q3 2023 and troughed at $253.9 million in Q1 2026.
• A 5-year average of $388.1 million and a median of $420.7 million in 2023 frame the typical range for Total Non-Current Liabilities.
• The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities soared 48.48% in 2022, then tumbled 39.24% in 2025.
• Over 5 years, Total Non-Current Liabilities stood at $475.2 million in 2022, then declined by 6.12% to $446.1 million in 2023, then retreated by 27.98% to $321.3 million in 2024, then dropped by 12.23% to $282.0 million in 2025, then declined by 9.96% to $253.9 million in 2026.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $253.9 million, $282.0 million, and $269.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.